Aldose Reductase as a Key Target in the Prevention and Treatment of Diabetic Retinopathy: A Comprehensive Review

Alexandra-Ioana Dănilă,Laura Andreea Ghenciu,Emil Robert Stoicescu,Sorin Lucian Bolintineanu,Roxana Iacob,Mihai-Alexandru Săndesc,Alexandra Corina Faur

DOI: https://doi.org/10.3390/biomedicines12040747

IF: 4.757

2024-03-28

Biomedicines

Abstract:The escalating global prevalence of diabetes mellitus (DM) over the past two decades has led to a persistent high incidence of diabetic retinopathy (DR), necessitating screening for early symptoms and proper treatment. Effective management of DR aims to decrease vision impairment by controlling modifiable risk factors including hypertension, obesity, and dyslipidemia. Moreover, systemic medications and plant-based therapy show promise in advancing DR treatment. One of the key mechanisms related to DR pathogenesis is the polyol pathway, through which aldose reductase (AR) catalyzes the conversion of glucose to sorbitol within various tissues, including the retina, lens, ciliary body and iris. Elevated glucose levels activate AR, leading to osmotic stress, advanced glycation end-product formation, and oxidative damage. This further implies chronic inflammation, vascular permeability, and angiogenesis. Our comprehensive narrative review describes the therapeutic potential of aldose reductase inhibitors in treating DR, where both synthetic and natural inhibitors have been studied in recent decades. Our synthesis aims to guide future research and clinical interventions in DR management.

biochemistry & molecular biology,medicine, research & experimental,pharmacology & pharmacy

What problem does this paper attempt to address?

The aim of this paper is to explore the critical role of Aldose Reductase (AR) in Diabetic Retinopathy (DR) and the potential of its inhibitors as a treatment method. Specifically:

1. **Research Background**: With the global incidence of diabetes continuously rising over the past 20 years, diabetic retinopathy has become a persistently high-incidence issue. Diabetic retinopathy can lead to vision impairment, thus necessitating early screening and appropriate treatment methods.

2. **Main Mechanism**: The paper points out that hyperglycemia caused by diabetes activates aldose reductase, which then converts glucose to sorbitol via the polyol pathway. This conversion leads to osmotic stress, the formation of advanced glycation end products (AGEs), and oxidative damage. These processes further cause chronic inflammation, increased vascular permeability, and neovascularization.

3. **Research Objective**: The main objective of the paper is to comprehensively review the efficacy of aldose reductase inhibitors in the treatment of diabetic retinopathy. The authors evaluate the preclinical and clinical evidence of both synthetic and natural aldose reductase inhibitors through a literature review, aiming to provide guidance for future research directions and clinical practice.

In summary, this paper attempts to explore how inhibiting aldose reductase can effectively prevent and treat diabetic retinopathy, thereby reducing the risk of vision impairment, through a comprehensive review and analysis.